Cargando…

MiR-1299 Impedes the Progression of Non-Small-Cell Lung Cancer Through EGFR/PI3K/AKT Signaling Pathway

BACKGROUND: Non-small-cell lung cancer (NSCLC) is one of the most malignant tumors. In which, numerous miRNAs had been reported to participate in the pathogenesis. However, the expression and function of miR-1299 in NSCLC are not clear. METHODS: To explore the roles of miR-1299 in NSCLC, we detected...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cao, Shengya, Li, Longfei, Li, Jia, Zhao, Hongying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7398754/ https://www.ncbi.nlm.nih.gov/pubmed/32801771 http://dx.doi.org/10.2147/OTT.S250396

Ejemplares similares

The role and underlying mechanism of miR-1299 in cancer
por: Kaiyuan, Deng, et al.
Publicado: (2021)

Circ_0006404 Accelerates Prostate Cancer Progression Through Regulating miR-1299/CFL2 Signaling
por: Li, Peihuan, et al.
Publicado: (2021)

Long non-coding MELTF Antisense RNA 1 promotes and prognosis the progression of non-small cell lung cancer by targeting miR-1299
por: Chai, Jin, et al.
Publicado: (2022)

miR-223 reverses the resistance of EGFR-TKIs through IGF1R/PI3K/Akt signaling pathway
por: HAN, JING, et al.
Publicado: (2016)

MiR-124-3p impedes the metastasis of non-small cell lung cancer via extracellular exosome transport and intracellular PI3K/AKT signaling
por: Zhu, Qing, et al.
Publicado: (2023)

MiR-106b and miR-93 regulate cell progression by suppression of PTEN via PI3K/Akt pathway in breast cancer
por: Li, Nana, et al.
Publicado: (2017)

MiR-125 inhibited cervical cancer progression by regulating VEGF and PI3K/AKT signaling pathway
por: Fu, Ke, et al.
Publicado: (2020)

Activation of EGFR-PI3K-AKT signaling is required for Mycoplasma hyorhinis-promoted gastric cancer cell migration
por: Duan, Hongying, et al.
Publicado: (2014)

Detection of Differentially Expressed MicroRNAs in Rheumatic Heart Disease: miR-1183 and miR-1299 as Potential Diagnostic Biomarkers
por: Li, Ni, et al.
Publicado: (2015)

miR-320/ELF3 axis inhibits the progression of breast cancer via the PI3K/AKT pathway
por: Zhang, Zhiqiang, et al.
Publicado: (2020)

miRNA-223 is an anticancer gene in human non-small cell lung cancer through the PI3K/AKT pathway by targeting EGFR
por: Ma, Hui-Ping, et al.
Publicado: (2019)

Serine Protease from Nereis virens Inhibits H1299 Lung Cancer Cell Proliferation via the PI3K/AKT/mTOR Pathway
por: Chen, Yanan, et al.
Publicado: (2019)

miR-494 promotes progression of retinoblastoma via PTEN through PI3K/AKT signaling pathway
por: Xu, Fen, et al.
Publicado: (2020)

miR-7/EGFR/MEGF9 axis regulates cartilage degradation in osteoarthritis via PI3K/AKT/mTOR signaling pathway
por: Jiang, Lifeng, et al.
Publicado: (2021)

miR-1299/NOTCH3/TUG1 feedback loop contributes to the malignant proliferation of ovarian cancer
por: Pei, Yuqing, et al.
Publicado: (2020)

Elevation of circular RNA circ_0005230 facilitates cell growth and metastasis via sponging miR-1238 and miR-1299 in cholangiocarcinoma
por: Xu, Yi, et al.
Publicado: (2019)

miR-185 suppresses progression of Ewing’s sarcoma via inhibiting the PI3K/AKT and Wnt/β-catenin pathways
por: Zhang, Shuai, et al.
Publicado: (2018)

LncZEB1-AS1 regulates hepatocellular carcinoma bone metastasis via regulation of the miR-302b-EGFR-PI3K-AKT axis
por: Ma, Zhen-jiang, et al.
Publicado: (2020)

LINC00638 promotes the progression of non-small cell lung cancer by regulating the miR-541-3p/IRS1/PI3K/Akt axis
por: Zhang, Juan, et al.
Publicado: (2023)

miR-7 reverses the resistance to BRAFi in melanoma by targeting EGFR/IGF-1R/CRAF and inhibiting the MAPK and PI3K/AKT signaling pathways
por: Sun, Xiaoyan, et al.
Publicado: (2016)

miR-183 promotes radioresistance of lung adenocarcinoma H1299 cells via epithelial-mesenchymal transition
por: Huang, Yi, et al.
Publicado: (2021)

JMJD8 Promotes Malignant Progression of Lung Cancer by Maintaining EGFR Stability and EGFR/PI3K/AKT Pathway Activation
por: Zhang, Bo, et al.
Publicado: (2021)

Hsa_circ_0001925 promotes malignant progression in triple‐negative breast cancer via miR‐1299/YY1 axis
por: Shen, Bin‐jie, et al.
Publicado: (2023)

[Corrigendum] miR‑1299/NOTCH3/TUG1 feedback loop contributes to the malignant proliferation of ovarian cancer
por: Pei, Yuqing, et al.
Publicado: (2023)

SNHG1 Promotes Malignant Progression of Glioma by Targeting miR-140-5p and Regulating PI3K/AKT Pathway
por: Cai, Ren-Duan, et al.
Publicado: (2020)

Circ-CREBBP inhibits sperm apoptosis via the PI3K-Akt signaling pathway by sponging miR-10384 and miR-143-3p
por: Ding, Ning, et al.
Publicado: (2022)

LINC01088/miR-22/CDC6 Axis Regulates Prostate Cancer Progression by Activating the PI3K/AKT Pathway
por: Li, Jianwei, et al.
Publicado: (2023)

Bladder cancer cell-secreted exosomal miR-21 activates the PI3K/AKT pathway in macrophages to promote cancer progression
por: Lin, Fan, et al.
Publicado: (2019)

MIR497HG‐Derived miR‐195 and miR‐497 Mediate Tamoxifen Resistance via PI3K/AKT Signaling in Breast Cancer
por: Tian, Yao, et al.
Publicado: (2023)

CCL18 promotes breast cancer progression by exosomal miR-760 activation of ARF6/Src/PI3K/Akt pathway
por: Huang, Xiaojia, et al.
Publicado: (2022)

Circular RNA CDR1as Alleviates Cisplatin-Based Chemoresistance by Suppressing MiR-1299 in Ovarian Cancer
por: Wu, Han, et al.
Publicado: (2022)

ZEB1-AS1/miR-133a-3p/LPAR3/EGFR axis promotes the progression of thyroid cancer by regulating PI3K/AKT/mTOR pathway
por: Xia, Wu, et al.
Publicado: (2020)

MiR‐210‐3p‐EphrinA3‐PI3K/AKT axis regulates the progression of oral cancer
por: Wang, Lin, et al.
Publicado: (2020)

Propofol Inhibits Microglial Activation via miR-106b/Pi3k/Akt Axis
por: Liu, Jianhui, et al.
Publicado: (2021)

miR-125a-5p post-transcriptionally suppresses GALNT7 to inhibit proliferation and invasion in cervical cancer cells via the EGFR/PI3K/AKT pathway
por: Cao, Qinxue, et al.
Publicado: (2020)

Simvastatin improves the homing of BMSCs via the PI3K/AKT/miR‐9 pathway
por: Bing, Weidong, et al.
Publicado: (2016)

miR-155 Regulates the Proliferation of Glioma Cells Through PI3K/AKT Signaling
por: Wu, Dahao, et al.
Publicado: (2020)

MiR‐3116 sensitizes glioma cells to temozolomide by targeting FGFR1 and regulating the FGFR1/PI3K/AKT pathway
por: Kong, Shiqi, et al.
Publicado: (2020)

Targeting EGFR/PI3K/AKT/mTOR Signaling in Hepatocellular Carcinoma
por: Bang, Jieun, et al.
Publicado: (2023)

miR-144-3p Contributes to the Development of Thyroid Tumors Through the PTEN/PI3K/AKT Pathway
por: Cao, Hui-Ling, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2i8rojugba9uv00j1q7abks8l0